Institutional investors purchased a net $1.8 million shares of OMER during the quarter ended September 2016, and now own 53.06% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 80.0 Thousand shares of Omeros Corp
VANGUARD INVESTMENTS AUSTRALIA L... Bought 1.7 Thousand shares of Omeros Corp
CREATIVE PLANNING, INC. Bought 1.5 Thousand shares of Omeros Corp